Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Study of Ovarex® (Oregovomab) MAb With Front-Line Chemotherapy for Ovarian Cancer Treatment
- Status
- TERMINATED
- Phase
- PHASE2
FR901228 in Treating Patients With Relapsed or Refractory Advanced Ovarian Epithelial Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Celecoxib in Preventing Cancer in Patients at High Risk for Ovarian Epithelial Cancer Who Are Undergoing Prophylactic Oophorectomy
- Status
- WITHDRAWN
- Phase
- NA
Efficacy of Å6 in Ovarian Cancer Patients Following First-Line Chemotherapy and a Rising CA125 Levels
- Status
- COMPLETED
- Phase
- PHASE2
Study of the Emotional Needs of Caregivers of Stem Cell Transplantation Patients
- Status
- COMPLETED
- Phase
- NA
A Study in Patients With Persistent or Recurrent Epithelial Ovarian or Primary Peritoneal Carcinoma
- Status
- TERMINATED
- Phase
- PHASE2
CA-125 in Screening Patients at High Risk for Ovarian Cancer
- Status
- WITHDRAWN
- Phase
- N/A
Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Timing of Surgery and Chemotherapy in Treating Patients With Newly Diagnosed Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Docetaxel and Oxaliplatin in Treating Patients With Stage III or Stage IV Ovarian Epithelial Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
A Study of the Safety and Effects of EMD 72000 in Subjects With Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer
- Status
- COMPLETED
- Phase
- PHASE1
UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Acupuncture to Improve Quality of Life in Patients With Advanced Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy in Treating Patients With Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Immunotoxin Therapy in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1